1. Home
  2. DGHI vs RVPH Comparison

DGHI vs RVPH Comparison

Compare DGHI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • RVPH
  • Stock Information
  • Founded
  • DGHI 2017
  • RVPH 2006
  • Country
  • DGHI United States
  • RVPH United States
  • Employees
  • DGHI N/A
  • RVPH N/A
  • Industry
  • DGHI Finance: Consumer Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGHI Finance
  • RVPH Health Care
  • Exchange
  • DGHI Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • DGHI 90.1M
  • RVPH 88.0M
  • IPO Year
  • DGHI N/A
  • RVPH N/A
  • Fundamental
  • Price
  • DGHI $3.03
  • RVPH $1.87
  • Analyst Decision
  • DGHI Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • DGHI 1
  • RVPH 5
  • Target Price
  • DGHI $2.50
  • RVPH $11.40
  • AVG Volume (30 Days)
  • DGHI 982.7K
  • RVPH 1.5M
  • Earning Date
  • DGHI 04-02-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • DGHI N/A
  • RVPH N/A
  • EPS Growth
  • DGHI N/A
  • RVPH N/A
  • EPS
  • DGHI N/A
  • RVPH N/A
  • Revenue
  • DGHI $42,146,057.00
  • RVPH N/A
  • Revenue This Year
  • DGHI N/A
  • RVPH N/A
  • Revenue Next Year
  • DGHI N/A
  • RVPH N/A
  • P/E Ratio
  • DGHI N/A
  • RVPH N/A
  • Revenue Growth
  • DGHI 100.56
  • RVPH N/A
  • 52 Week Low
  • DGHI $0.84
  • RVPH $0.60
  • 52 Week High
  • DGHI $3.77
  • RVPH $4.72
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 57.94
  • RVPH 48.62
  • Support Level
  • DGHI $2.81
  • RVPH $1.97
  • Resistance Level
  • DGHI $3.48
  • RVPH $2.14
  • Average True Range (ATR)
  • DGHI 0.47
  • RVPH 0.16
  • MACD
  • DGHI -0.01
  • RVPH -0.01
  • Stochastic Oscillator
  • DGHI 48.25
  • RVPH 40.43

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: